Taiwan · Delayed Price · Currency is TWD Lotus Pharmaceutical Statistics
Total Valuation
TPE:1795 has a market cap or net worth of TWD 50.72 billion. The enterprise value is 101.15 billion.
| Market Cap | 50.72B |
| Enterprise Value | 101.15B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Aug 11, 2025 |
Share Statistics
TPE:1795 has 262.81 million shares outstanding. The number of shares has decreased by -0.99% in one year.
| Current Share Class | 262.81M |
| Shares Outstanding | 262.81M |
| Shares Change (YoY) | -0.99% |
| Shares Change (QoQ) | -0.25% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 13.27% |
| Float | 131.96M |
Valuation Ratios
The trailing PE ratio is 13.08 and the forward PE ratio is 11.33.
| PE Ratio | 13.08 |
| Forward PE | 11.33 |
| PS Ratio | 2.08 |
| PB Ratio | 2.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.83 |
| P/OCF Ratio | 10.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.25, with an EV/FCF ratio of 29.57.
| EV / Earnings | 26.26 |
| EV / Sales | 4.14 |
| EV / EBITDA | 12.25 |
| EV / EBIT | 15.68 |
| EV / FCF | 29.57 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 2.36.
| Current Ratio | 1.59 |
| Quick Ratio | 0.95 |
| Debt / Equity | 2.36 |
| Debt / EBITDA | 6.86 |
| Debt / FCF | 16.55 |
| Interest Coverage | 3.31 |
Financial Efficiency
Return on equity (ROE) is 17.03% and return on invested capital (ROIC) is 7.22%.
| Return on Equity (ROE) | 17.03% |
| Return on Assets (ROA) | 5.44% |
| Return on Invested Capital (ROIC) | 7.22% |
| Return on Capital Employed (ROCE) | 7.07% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | 22.22M |
| Profits Per Employee | 3.50M |
| Employee Count | 1,099 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, TPE:1795 has paid 849.87 million in taxes.
| Income Tax | 849.87M |
| Effective Tax Rate | 18.08% |
Stock Price Statistics
The stock price has decreased by -12.07% in the last 52 weeks. The beta is 0.37, so TPE:1795's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -12.07% |
| 50-Day Moving Average | 209.84 |
| 200-Day Moving Average | 252.62 |
| Relative Strength Index (RSI) | 42.34 |
| Average Volume (20 Days) | 1,998,183 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1795 had revenue of TWD 24.42 billion and earned 3.85 billion in profits. Earnings per share was 14.75.
| Revenue | 24.42B |
| Gross Profit | 13.38B |
| Operating Income | 6.45B |
| Pretax Income | 4.70B |
| Net Income | 3.85B |
| EBITDA | 8.12B |
| EBIT | 6.45B |
| Earnings Per Share (EPS) | 14.75 |
Balance Sheet
The company has 6.20 billion in cash and 56.62 billion in debt, with a net cash position of -50.43 billion or -191.88 per share.
| Cash & Cash Equivalents | 6.20B |
| Total Debt | 56.62B |
| Net Cash | -50.43B |
| Net Cash Per Share | -191.88 |
| Equity (Book Value) | 24.03B |
| Book Value Per Share | 91.44 |
| Working Capital | 9.66B |
Cash Flow
In the last 12 months, operating cash flow was 4.73 billion and capital expenditures -1.31 billion, giving a free cash flow of 3.42 billion.
| Operating Cash Flow | 4.73B |
| Capital Expenditures | -1.31B |
| Depreciation & Amortization | 1.67B |
| Net Borrowing | 10.16B |
| Free Cash Flow | 3.42B |
| FCF Per Share | 13.02 |
Margins
Gross margin is 54.77%, with operating and profit margins of 26.41% and 15.77%.
| Gross Margin | 54.77% |
| Operating Margin | 26.41% |
| Pretax Margin | 19.25% |
| Profit Margin | 15.77% |
| EBITDA Margin | 33.24% |
| EBIT Margin | 26.41% |
| FCF Margin | 14.01% |
Dividends & Yields
This stock pays an annual dividend of 2.56, which amounts to a dividend yield of 1.33%.
| Dividend Per Share | 2.56 |
| Dividend Yield | 1.33% |
| Dividend Growth (YoY) | 24.34% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 39.45% |
| Buyback Yield | 0.99% |
| Shareholder Yield | 2.31% |
| Earnings Yield | 7.59% |
| FCF Yield | 6.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for TPE:1795 is 367.00, which is 90.16% higher than the current price. The consensus rating is "Buy".
| Price Target | 367.00 |
| Price Target Difference | 90.16% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | -1.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPE:1795 has an Altman Z-Score of 1.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 4 |